SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.410
-0.050 (-1.45%)
Sep 15, 2026, 4:00 PM EDT - Market closed
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $310.26 million as of September 15, 2026. Its market cap has increased by 1,305.72% in one year.
Market Cap
310.26M
Enterprise Value
212.76M
1-Year Change
1,305.72%
Ranking
Category
Stock Price
$3.41
ChartMarket Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $310.26M, an increase of 137.29%. That is a compound annual growth rate of 16.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 310.26M | 74.26% |
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 345.40M |
| Zentalis Pharmaceuticals | 331.35M |
| Q32 Bio | 324.78M |
| Agenus | 321.00M |
| Upstream Bio | 318.22M |
| InflaRx | 312.42M |
| Vanda Pharmaceuticals | 311.38M |
| Abeona Therapeutics | 310.51M |